BioSpace News Archive

Landos Biopharma, Inc. (NASDAQ: LABP), a clinical-stage biopharmaceutical company developing novel, oral medicines for patients with autoimmune diseases, today announced that it will participate at the Jefferies Healthcare Conference, to be held from June 7-9, 2023 in New York, NY.

According to our new research study on “Next generation sequencing Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Component, Application, and End User,” the market is expected to reach US$ 26,501.2 million by 2025 from US$ 4,274.9 million in 2016;

According to The Insight Partners market research study titled ‘Transradial Access Market to 2027 – Global Analysis and Forecasts by Product, Application and End User.’ The Global Transradial Access Market is expected to reach US$ 2,961.79 Mn in 2027 from US$ 1,574.97 Mn in 2018.

According to The Insight Partners market research study of Brain Aneurysm Treatment Market Forecast to 2027 – Covid-19 Impact and Global Analysis by Type, Condition, and End User.

According to The Insight Partners market research study titled ‘Epigenetics Market to 2025 - Global Analysis and Forecasts by Product, Technology, Application and End User. T

Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced that Michele Korfin, Chief Operating and Chief Commercial Officer, will present corporate highlights at the upcoming Jefferies Healthcare Conference on June 8, 2023 at 9:30 a.m. ET.

Bruker Corporation announced the Company will host an Investor Day on June 15th, 2023, starting at 10:00 AM EDT, at Bruker’s Headquarters located at 40 Manning Road, Billerica, MA, with the live webcast starting at 11:00 AM EDT.

Enliven Therapeutics, Inc., a clinical-stage precision oncology company focused on the discovery and development of next-generation small molecule kinase inhibitors, announced that management will present at the following investor conferences in June.

Ardelyx, Inc. today announced that Mike Raab, president and chief executive officer of Ardelyx, will participate in a fireside chat at the Jefferies Healthcare Conference on Wednesday, June 7, 2023, at 8:30 a.m. ET in New York City.

Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company targeting diseased macrophages, today announced three poster presentations, including a selected Elevator Pitch Presentation at the 2023 Annual Meeting of the International Society for Cell & Gene Therapy (ISCT).